Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -182,814 | -122,321 | -76,206 | -37,599 | -108,897 |
| Depreciation Amortization | 869 | 1,735 | 1,186 | 563 | 841 |
| Accounts receivable | 13,903 | 16,724 | 18,149 | 16,504 | -17,853 |
| Other Working Capital | 26,875 | 18,472 | 14,074 | 10,981 | -872 |
| Other Operating Activity | 6,059 | -7,187 | -11,525 | -13,730 | 37,197 |
| Operating Cash Flow | $-135,108 | $-92,577 | $-54,322 | $-23,281 | $-89,584 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,342 | -27,911 | 5,979 | 10,840 | 78,277 |
| PPE Investments | -514 | -359 | -187 | -116 | -343 |
| Investing Cash Flow | $-6,856 | $-28,270 | $5,792 | $10,724 | $77,934 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 119,867 | N/A | N/A | N/A | 19,477 |
| Debt Repayment | -52,420 | -5,000 | N/A | N/A | N/A |
| Common Stock Issued | 95,725 | 94,012 | 93,646 | 266 | 59,739 |
| Other Financing Activity | 137,417 | 14,817 | 14,817 | 0 | 19,882 |
| Financing Cash Flow | $300,589 | $103,829 | $108,463 | $266 | $99,098 |
| Beginning Cash Position | 115,723 | 115,723 | 115,723 | 115,723 | 28,275 |
| End Cash Position | 274,348 | 98,705 | 175,656 | 103,432 | 115,723 |
| Net Cash Flow | $158,625 | $-17,018 | $59,933 | $-12,291 | $87,448 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,108 | -92,577 | -54,322 | -23,281 | -89,584 |
| Capital Expenditure | -514 | -359 | -187 | -116 | -343 |
| Free Cash Flow | -135,622 | -92,936 | -54,509 | -23,397 | -89,927 |